Cargando…
A framework to assess the added value of subgroup analyses when the overall treatment effect (TE) was significant
Autores principales: | Sun, Hong, Vach, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3980951/ http://dx.doi.org/10.1186/1745-6215-14-S1-P32 |
Ejemplares similares
-
A framework to assess the impact of applying formal criteria to check clinical relevance on top of statistical significance
por: Vach, Werner, et al.
Publicado: (2013) -
Inconsistency between overall and subgroup analyses
por: Wang, Hongyue, et al.
Publicado: (2022) -
Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015) -
Potential role of “the compensating benefit” in claiming non-inferiority
por: Beryl, Primrose, et al.
Publicado: (2013) -
Spatial patterns of clinically significant G6PD deficiency: variants, prevalence and an overall national risk index
por: Howes, Rosalind E, et al.
Publicado: (2012)